Results 251 to 260 of about 42,909 (288)
Some of the next articles are maybe not open access.

Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases

Amino Acids, 2007
Advanced glycation end-products (AGEs) are formed from the so-called Amadori products by rearrangement followed by other reactions giving rise to compounds bound irreversibly. The structure of some of them is shown and the mechanism of formation is described.
M.A. GRILLO, COLOMBATTO, Sebastiano
openaire   +2 more sources

Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents

Critical Reviews in Food Science and Nutrition, 2017
This study was aimed to review and collate effects of curcumin on generation of advanced glycation end products (AGEs) and AGEs induced detrimental agents.Pubmed, Googlescholar, ScienceDirect, and Scopus databases were searched. Searching was not limited to specific publication period. Only English language original articles (in vitro, experimental and
Mohammad, Alizadeh, Sorayya, Kheirouri
openaire   +2 more sources

Advanced Glycation End Products (AGEs) in Diabetic Complications

2017
Hyperglycemic condition in diabetes accelerates formation of advanced glycation end products (AGEs) that are formed as a result of series of reaction between reducing sugars and proteins. Accumulation of AGEs has been implicated in development of insulin resistance as well as in the pathogenesis of diabetic complications.
Shweta Bhat   +3 more
openaire   +1 more source

Role of Advanced Glycation End Products in Aging Collagen

Gerontology, 1998
The collagen structure of young and old rats was examined using a scanning force microscope (SFM). Rat tail tendons of 8- and 24-month-old Wistar rats were frayed by two blades and examined using a Nanoscope III SFM. In the same tendons, the pentosidine concentrations, a marker of the Maillard reaction, were determined by HPLC.
P. Odetti   +5 more
openaire   +1 more source

Serum advanced glycation end products (AGEs) are associated with insulin resistance

Diabetes/Metabolism Research and Reviews, 2011
AbstractBackgroundIn addition to the important role of advanced glycation end products (AGEs) in the pathogenesis of diabetic vascular complications, recent data suggest that advanced glycation end products can also impair insulin action in vitro. We have investigated whether circulating advanced glycation end products are associated with insulin ...
Tan, KCB, Shiu, SWM, Tam, X, Wong, Y
openaire   +4 more sources

[Advanced glycation end products (AGEs) and renal failure].

Przeglad lekarski, 2006
In the last decade a central role has been attributed to advanced glycation end products (AGE's) in the progression of accelerated atherosclerosis and progresion of chronic renal failure, especially in diabetic nephropathy. Deleterious effects of high AGE's concentration was observed mainly in diabetic hemodialyzed patients. D. M.
Robert, Kurowski, Jacek, Manitius
openaire   +1 more source

Advanced glycation end-products (AGES) and heart failure

European Journal of Heart Failure, 2007
Advanced glycation end-products (AGEs) are molecules formed during a non-enzymatic reaction between proteins and sugar residues, called the Maillard reaction. AGEs accumulate in the human body with age, and accumulation is accelerated in the presence of diabetes mellitus. In patients with diabetes, AGE accumulation is associated with the development of
Hartog, Jasper W. L.   +4 more
openaire   +1 more source

Advanced glycation end products and skin ageing - A Review

FLORA AND FAUNA
Advanced glycation end products (AGEs) are compounds formed by non-enzymatic reaction between the carbonyl group of reducing sugars and amino group of proteins, nucleic acids, and lipids. They are formed in body tissues by both endogenous and exogenous ways.
Sanjenbam Kabita   +4 more
openaire   +1 more source

Cancer statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Rebecca L Siegel   +2 more
exaly  

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Michael L Cheng   +2 more
exaly  

Home - About - Disclaimer - Privacy